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The cytochrome P450s (CYPs) catalyze the oxidation of a vast range of environmental toxins and drugs. Collectively, the CYPs provide an impressive catalytic potential for the metabolism and elimination of any potential toxin to which we may be exposed (1, 2) . Recently, it has become apparent that the metabolism of many compounds by CYPs, including CYP isoforms 3A4, 1A2, 2C9, occurs with non-Michaelis-Menten behavior. Plots of reaction velocity vs.
[substrate] are sigmoidal or biphasic, as with allosteric positive homotropic effects or negative homotropic effects, respectively (3) (4) (5) (6) . The mechanisms underlying such allostery are actively debated, and may be isoform-and substrate-dependent. Possible mechanisms include multiple ligand binding to a single active site, multiple ligand binding at spatially distinct sites, multiple ligand binding to CYP conformational isomers with distinct kinetic properties, or a combination of these (4, (6) (7) (8) (9) . Although allosteric behavior is now well documented for CYPs, its toxicological advantage, if any, has not been considered. Here, the term toxicological advantage is defined as any change in system parameters that results in a decrease in the integrated area under the curve (AUC) of the toxicity vs. time function. 'Toxicity' is a substrateand product-dependent function described within.
Allostery is observed usually with complex oligomeric enzymes that control key regulatory processes in intermediary metabolism. These regulatory mechanisms rely on highly specific molecular recognition of allosteric 'effector' molecules or specific homotropic interactions, and have evolved because the allosteric properties of such enzymes yield physiological advantages. Thus, functional allostery is generally coupled to biological specificity. In most cases, the allosteric behavior affords control of an enzymatic reaction or metabolic pathway for which the advantage of allostery is easily rationalized. However, these allosteric traits are obscured with CYPs. Has there been an evolutionary selective pressure for by guest on November 19, 2017 http://www.jbc.org/ Downloaded from 6 CYPs to exhibit non-hyperbolic reaction kinetics? If so, how can functional allostery be achieved in the absence of specific molecular recognition? These questions are not entirely insignificant; an understanding of the biological advantage of CYP cooperativity could yield insight into their allosteric mechanisms, and it could aid in metabolism-based drug design. Here we examine through kinetic simulations the possibility that allosteric kinetic behavior provides a detoxification advantage when bioactivated toxic products are a significant threat.
Elegant theoretical analyses of 'optimized' enzymes have focused predominantly on features that maximize flux of substrate through an enzymatic cycle or through a metabolic pathway (10) (11) (12) (13) (14) . Although the details of these analyses differ, a common focus has been the utility for an enzyme to optimize k cat /K M while not lowering K M much below the physiological concentration of substrate. Extremely low K M values may result in 'wasted' binding energy. A second common feature of 'optimized' enzymes and enzymatic pathways is their tendency to have multiple steps with similar rate, so no single intermediate accumulates. Knowles and coworkers have stressed that the optimal kinetic parameters must take into account the biological niche of the enzyme being considered (10). Wolfenden and colleagues have emphasized that 7 Bioactivation processes underscore the fact that, for changes in the xenobiotics to which we are exposed on the evolutionary time scale, naive species can not 'know' which metabolites of any compound will be toxic. Therefore, evolutionary pressure may not eliminate completely the possibility of bioactivation of previously unencountered xenobiotics. Instead, for enzymatic detoxification evolutionary optimization of enzyme parameters becomes a probabilistic process.
Therefore, when considering whether the allostery observed for CYP-dependent reactions can be rationalized in terms of their detoxification role, we must account for inadvertent bioactivation.
We have suggested previously that detoxification enzymes such as CYPs may evolve, not only to metabolize a wide range of structurally unrelated xenobiotics, but also to minimize the probability of bioactivation of previously unencountered xenobiotics by distributing the toxic load into multiple products (20) . We have referred to this probabilistic process as 'distributive catalysis.' Distributive catalysis will provide a detoxification advantage if the toxicity of a compound and its metabolites exhibit sublinear, or threshold, dose-response relationships. The existence of sublinear toxic dose-response curves at low toxin concentration has been suspected or documented for many cases, and may be a general feature of toxic responses in higher organisms (21) (22) (23) (24) . Here, results of theoretical simulations are described in which the kinetics of substrate turnover and product formation are compared with two indices of toxicity: the total toxin concentration and the relative toxicity of their sum. The results suggest that non-hyperbolic velocity vs.
[substrate] curves, for CYP metabolism of toxins, can sometimes afford a toxicological advantage when toxic thresholds exist. At low substrate concentration, this advantage exists when the overall clearance of the total toxin load is slower than with a corresponding non-allosteric enzyme. This advantage results from the fact that the allosteric kinetics provide a type of 'distributive catalysis.' At high substrate concentrations, the 'distributive' advantage is best accomplished with faster turnover, as achieved by 8 allostery. Thus, the CYPs may represent functional allostery in the absence of highly specific molecular recognition.
Methods
Models were created and simulations performed with Kinecyte TM (Raintown Biotech, Seattle WA), a cell biological kinetic modeling program, as described previously (20) . The initial velocities are based on simulations of 1-2 minutes of steady state product formation, for which the rate of product formation was linear vs. time. For all models used here, the free substrate is in rapid equilibrium with the enzyme-bound species. For calculation of area under the curve (AUC) of ΣTox, the output from Kinecyte TM was exported to Origin TM .
In the previously described model for distributive catalysis (20) , we defined two parameters to monitor the toxicity that may be expected due to a xenobiotic, as other system parameters change. The 'total toxin concentration' (Σ[Tox i ]) is the sum of the concentrations of free substrate and free product throughout the simulation. In an isolated conversion of S ⇒ P during steady state, this sum differs from the starting concentration of substrate only by the amount of substrate and product sequestered in complexes with the enzyme, which we have defined as 'non-toxic,' because compounds sequestered by the enzyme are unlikely to contribute to toxicity. For the cases examined here, the sequestration effect is negligible, but it may be an interesting additional device exploited by detoxification enzymes, and we include this parameter as a check for internal consistency. The second parameter, ΣTox is the 'relative toxicity' that results, assuming that each free substrate and free product has an equal a priori probability of being toxic. Obviously, in a real system either S or P is likely to be more toxic. However, the 9 condition that S and P are equally toxic emphasizes the probabilistic nature of detoxification (24) . The slope of the threshold increases with K, as shown in Figure 1 . Note that K is not a Hill coefficient for the CYP enzyme catalyzing the conversion of S to P, but rather for the toxic responses of S and P. As discussed previously, this definition of relative toxicity provides a convenient method for calculating the 'probable toxicity' with varying threshold steepness (K), when no a priori knowledge for the toxicities of S or P is available, and when their toxicities are assumed to be equal. Note that when K = 1, no threshold exists. We have suggested that a species with no prior exposure to a toxin, S, will have not experienced selective pressure favoring or disfavoring its conversion to P, and it must be assumed a priori that their toxicities are equal. The rate equations used to calculate the change in concentration of each species were:
Results
Construction of a Model. As described in Methods, the model for the toxin dose-response curve is shown in Figure 1 . The toxicity function that yields the responses is also described in 11 hyperbolic velocity vs.
[substrate] plot, as shown in Figure 2B . This enzyme, characterized by
Michaelis-Menten kinetics is referred to as 'MM.' For the MM enzyme, the rate constants for binding and dissociation of product were 1X10 6 M -1 sec -1 and 2.0 sec As shown in Figure 2A , P may be subsequently metabolized or 'cleared' by other enzymatic, chemical, or physical process, which are left unspecified. Obviously, the rate constant for this elimination, k elim , will be a determinant of steady state concentrations of P.
Although this parameter is not controlled by the detoxification enzymes modeled here, k elim is part of their biological niche, and a range of values is included.
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Having constructed kinetic models that mimic CYP-dependent metabolism, the relative toxicity expected for a substrate can be studied for different enzyme parameters. Simulations are presented below which track the relative toxicity when a model enzyme is presented with a single dose of a toxic substrate.
Positive Homotropic Effects
Low Figure 3C ), that reflects the detoxification due to sequestration of substrate and product by the enzyme (at .01 µM), prior to complete conversion of S to P. Figure 3D demonstrates that for K = the relative toxicity, due to the distribution of toxic species in two forms, each with a threshold.
As all of the substrate is converted to P, this advantage due to distribution is lost by 200 -300 sec, and the relative toxicity ends at the same level at which it began. For each K value, the minimum relative toxicity is at ~ 50 secs, which corresponds to the point at which one-half of the substrate has been converted to P ([S]/[P] = 1). Note that K is not a property of the CYP enzyme, so changing K does not change the rate at which this minimum is reached. However, as the toxic threshold increases with K, the toxicity decreases further when [S]/[P] = 1.
In the next set of simulations, the MM enzyme is converted to a sigmoidal 'V system' by decreasing the value for k cat1 . At low concentrations of S, we expect a slower overall conversion of S to P, due to a decrease in velocity, as shown in Figure 4 . Whereas the MM enzyme converted all of S to P within 400 sec, this V system requires more than 1000 sec. to sequestration at short times. As with the MM system, the relative toxicity, Figure 4D , exhibits a transient decrease, with the minimum value of relative toxicity decreasing with increasing K.
Each value of K affords a minimum at the same time point, which corresponds to one-half reaction completion. In comparison to the MM system, the relative toxicity reaches its minimum value later in the process (~200 sec), and takes much longer to reach the value of 1, corresponding to complete conversion of S to P. In essence, all of the processes observed for the MM enzyme (Figure 3 ) are qualitatively the same as in Figure 4 , but they occur more slowly for the V system , and this appears to provide a detoxification advantage by extending the period over which the relative toxicity remains below a value of 1.
Together, these simulations indicate that a toxic advantage is gained for the allosteric V system, where the relative toxicity is transiently reduced for a longer period than for the MM 14 enzyme. In fact, this can be quantitatively compared as integrated area under the curve (AUC), the index of toxic effect. The AUCs of the toxicity function (ΣTox) for the MM enzyme vs. the V system are plotted in Figure 5 . At K>1, there is a dramatic decrease in the toxic AUC when sigmoidal kinetics apply to the CYP responsible for toxin metabolism. The resulting difference in AUC (AUC MM -AUC sig ) is positive, and advantageous. This is the simple result of extending the period during which the toxins are distributed in 2 pools, S and P. This, in turn, appears to result from slowing down the rate of conversion. That is, the slower enzymes are advantageous when there is an equal probability that S or P is toxic, and when the concentration dependence of their toxicities exhibits a threshold. Interestingly, the slow enzyme could provide an advantage also if P were more toxic than S, as k elim approaches zero.
This prompts an obvious question. Would a MM system that was slower than the one used here afford the same advantage, or is the advantage dependent on sigmoidal kinetics? Of course, the answer to these questions is that sigmoidal kinetics are not required at any single value of [S] 0 . This is easily demonstrated with an additional simulation, wherein the V max was decreased relative to the 'parent MM' enzyme above. Specifically, the k 1 , k 2 , k -1 , and k -2 values were the same as the parent MM enzyme. However both k cat1 and k cat2 were decreased to 0.5 sec
As with the effects on relative toxicity observed above, the differences between the slow MM enzyme and the others is most pronounced at higher K values. However, the simple result (not shown) is that the slower enzyme, whether the slow MM or V system, provides a detoxification advantage at low [S] 0 when toxic thresholds exist and enzymatic products are toxic. 
Conclusions and Discussion
Possibly, the allosteric behavior of CYPs is not a feature selected through evolutionary advantage, and, instead, allostery is a physico-chemical by-product of substrate diversity. The non-specific binding sites of CYPs may yield a heterogeneous ensemble of energetically coupled states, which in turn leads to allostery without function. On the other hand, in light of the nearly 'perfect' evolutionary optimization (11) of some enzymes and their amazing 'proficiency' at catalyzing difficult reactions (12) , it is reasonable to speculate that the allosteric properties of
CYPs provide a functional detoxification advantage that would be maintained or improved through further evolution. It is striking that, although allostery has become widely documented for CYPs (4) (5) (6) (7) (8) (9) 27) , no toxicological implications have been suggested. We propose that the advantage of faster metabolism is not at all intuitive, in light of the commonly observed bioactivation of substrate to toxic products.
Here, deterministic kinetic models for positive homotropic and negative homotropic CYPs were constructed, and compared to non-allosteric (Michaelis-Menten) models, in order to explore the probabilistic aspects of detoxification that are present when both substrate and product are potentially toxic. The results demonstrate that positive homotropic allostery can provide a detoxification advantage at low to intermediate substrate concentration within a biological niche that includes the possibility of substrate bioactivation to toxic products, if thresholds exist in the toxin dose-response curves. At high substrate concentrations, at which the sigmoidal enzyme and MM enzyme converge, the allostery provides no advantage, but also no disadvantage. It must be emphasized that the models used do not explicitly define an absolute 'toxic concentration' or toxin dose-response curve. That is, no specific toxic thresholds were defined in terms of [toxin] . Only the shape of the dose response curve was explicitly defined.
Thus, the observed detoxification advantage for the allosteric enzymes is a general feature whenever K>1, independent of absolute concentration of toxic threshold. The magnitude of this advantage or disadvantage depends on the ratio of k cat /k elim , which determines the degree of product accumulation. In as much as most drugs yield metabolites that accumulate enough to be detected, the ratios of k cat /k elim used here are physiologically reasonable. Also, the advantage observed when k cat and k elim are appropriately 'matched' is modest, particularly at low K values.
However, the modest advantage gained for these allosteric systems could provide a contribution to acute detoxification responses. concentration, but they minimize the probability of toxicity over the widest range of substrate concentrations.
Obviously, the importance of any toxicological advantage resulting from CYP allostery is speculative, to the extent that several simplifying assumptions have been used to construct and test the models. Still, the initial analysis considered here suggests the possibility of functional allostery for CYPs in the absence of biological specificity. Although the detoxification advantage demonstrated here for non-hyperbolic CYPs is modest, any functional allostery in the absence of molecular specificity would be remarkable. The biphasic enzyme provides an advantage at all combinations of K and k elim . Blue, K= 2; Red, K = 3; Yellow, K = 4.
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